(218 days)
The SV Spectrum MRC Central Venous Catheter is indicated to provide short-term (
The SV Spectrum MRC Central Venous Catheter (CVC) is a single-use, antibiotic impregnated, antimicrobial coated, power injectable catheter that is percutaneously inserted into the vasculature using the Seldinger technique, and advanced over a wire guide until its tip is positioned above the superior vena cava-right atrium (SVC-RA) junction within the lower third of the SVC. The SV Spectrum MRC Central Venous Catheter, 7 Fr triple lumen CVC, is made from an aliphatic polyether-based polyurethane catheter shaft with a radiopaque constituent and a bonded soft distal tip. The catheter shaft is impregnated with Spectrum® (minocycline, rifampin) antimicrobial agents and coated with chlorhexidine antiseptic. The SV Spectrum MRC Central Venous Catheter is not intended for treatment of existing infections in patients; the presence of the three antimicrobial agents has been shown to reduce microbial colonization of the catheter.
The SV Spectrum MRC CVC has demonstrated efficacy against the following organisms:
- Staphylococcus aureus
- Staphylococcus epidermidis
- Enterococcus faecalis
- Escherichia coli
- Klebsiella pneumoniae
- Acinetobacter baumanni
- Candida albicans
- Candida glabrata
The effectiveness was evaluated using in vitro methods. The antimicrobial activity of these agents is localized to the internal and external catheter surfaces.
The working length (15, 20, or 25 cm) of the catheter is measured from distal tip to the double bar line approximately 1.5 cm distal to the manifold. The catheter shaft features centimeter length markings. The proximal portion of the SV Spectrum MRC Central Venous Catheter, like the predicate catheter, has three extension tubes with injection-molded Luer hubs connected to a manifold. The injection-molded manifold with suture wings serves as the transition point for lumens of the extension tubes into each lumen of the catheter shaft. All three lumens are power injectable; the maximum flow rate is labeled on the hub of each extension tube.
The SV Spectrum MR Central Venous Catheter is identical to the SV Spectrum MRC Central Venous Catheter except that it is not coated with chlorohexidine antiseptic.
The SV Central Venous Catheter is identical to the SV Spectrum MRC Central Venous Catheter and SV Spectrum MR Central Venous Catheter except it is not impregnated with minocycline or rifampin, nor is it coated with chlorhexidine antiseptic.
This FDA 510(k) clearance letter pertains to a central venous catheter and, as such, does not contain information about the acceptance criteria and study that proves the device meets acceptance criteria for an AI/ML-driven medical device.
The document states:
- "Software: Not applicable. The device contains no software." (Page 18)
- The performance testing for this device focuses on mechanical and shelf-life properties, biocompatibility, and antimicrobial efficacy (for certain versions), all of which are standard for physical medical devices and unrelated to AI/ML performance.
Therefore, I cannot provide the requested information based on the provided text. The prompt asks for details specifically relevant to AI/ML device performance and testing (e.g., sample size for training/test sets, expert adjudication methods, MRMC studies, standalone algorithm performance, ground truth establishment) which are not present in this document as it's for a non-software, non-AI medical device.
§ 880.5200 Intravascular catheter.
(a)
Identification. An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.(b)
Classification. Class II (performance standards).